Two novel, distinct truncated forms of apolipoprotein B (apo B) designated as apo B-90 and apo B-40 were found in five members of a kindred with hypobetalipoproteinemia. Sodium dodecyl sulfate gels and immunoblots of plasma or low density llpoproteln (LOL) (d=1.019 to 1.063 g/ml) of the affected members demonstrated the presence of one or both of the truncated apo B bands. Employing four monoclonal antl-LDL antibodies with defined regional specificities, we demonstrated that amlno terminal epttopes of the truncated apo Bs were Intact, but that 10% and 60%, respectively, of the carboxyl terminal regions were absent Tnrombln digestion of apo B-90 generated an abnormally small T2 fragment, confirming that approximately 550 amlno acids had been deleted from the carboxyl terminus of apo B-100. A polipoprotein B (apo B) is important in lipoprotein metabolism. Under normal conditions, human apo B is secreted in two forms, one with apparent A^=550 Kd (apo B-100) from liver in association with very low density lipoprotein (VLDL) and another with apparent M r =246 Kd (apo B-48) from intestine in association with chylomicrons. Hepatic VLDL are converted to intermediate density lipoprotein (IDL) and low density lipoprotein (LDL), which are removed from circulation via LDL receptormediated endocytosis, and apo B-100 serves as the ligand for lipoprotein recognition in this case.
A polipoprotein B (apo B) is important in lipoprotein metabolism. Under normal conditions, human apo B is secreted in two forms, one with apparent A^=550 Kd (apo B-100) from liver in association with very low density lipoprotein (VLDL) and another with apparent M r =246 Kd (apo B-48) from intestine in association with chylomicrons. Hepatic VLDL are converted to intermediate density lipoprotein (IDL) and low density lipoprotein (LDL), which are removed from circulation via LDL receptormediated endocytosis, and apo B-100 serves as the ligand for lipoprotein recognition in this case.
Familial hypobetalipoproteinemia (HBL), is characterized in the homozygous state by symptoms that resemble abetalipoproteinemia (ABL). Table 1 . Those individuals whose total and low density lipoprotein cholesterol concentrations are less than the fifth percentile of age-and sex-matched controls are indicated wtth stars (*). Deceased members of the kindred are identified by a dagger (t). Apo B restriction fragment length polymorphism (RFLP) and variable number of tandem repeat (VMTR) pedigree analysis were performed on DNA from members of the SH kindred. Restriction enzymes Xba I, EcoR I, and Pvu II are indicated by the letters X, R, and P, respectively. The VNTR typing Is also given. Only siblings of the proband and the single tested sister-in-law and niece are shown. The RFLP and VNTR haplotypes are listed vertically below each symbol corresponding to a family member. The lower-case letters were assigned to each unique "allele" of apo B to match the RFLP haplotypes to the observed apo B haplotypes. The parents must have had haplotypes apo B-100/apo B-90 and apo B-100/apo B-40 and RFLP haplotypes a,d and b,c, respectively, as shown in the rectangle in the lower left-hand comer. Letters e and f represent two unique apo B alleles associated with the wife of sibling II-8, and these do not appear in the SH kindred.
of apo B at amino acid residue 1799, and the second variant resulted from a mutation in the arginine codon (residue 1306), converting it to a stop codon. 10 It has not been resolved as to how genes coding for truncated variants of apo B cause hypobetalipoproteinemia.
Several mutations of the apo B gene that give rise to apo B protein with altered binding to the LDL receptor on cells have been recently documented. 121314 As a result, these variant apo B proteins in humans 1214 or pigs 13 have LDL concentrations that are higher than normal due to decreased catabolism of the apo B-containing lipoprotein particles determined either in vitro or in vivo. It is clear that the study of variant apo B protein forms is of extreme value in elucidating key features of apo B structurefunction relationships and in understanding lipid transport.
We have begun to screen populations for structural variants of apo B using monoclonal antibodies that distinguish between conformatjonalry altered apo B epitopes. 1516 Here we report our finding of two novel and distinct variant forms of apo B, apo B-90 and apo B-40, in a kindred with HBL. Both forms of apo B are associated with lower than fifth percentile concentrations of LDL cholesterol. A unique observation is that apo B-90 containing LDL particles bind to LDL receptors on fibroblasts with higher affinity than normal apo B-100 LDL, and this is one factor giving rise to the hypobetalipoproteinemia in this kindred.
Methods Subjects
The proband of the SH kindred (11-1, Figure 1 and Table 1) is a 52-year-old white woman. A very low concentration of plasma cholesterol was found during a hospital admission on 10/7/87 for chest pain. She had no prior history of chest pain; however, she had a 60-pack-year history of cigarette smoking. Her only other complaint included occasional episodes of abdominal cramping and flatulence, attributable to irritable bowel syndrome. There were no symptoms of peripheral neuropathy, locomotor abnormalities, night blindness, or steatorrhea. On physical examination, she was well developed, well nourished, and in no distress. Her blood pressure was 120/70 and her pulse was 70 and regular. Her height and weight are shown in Table 1 . Her physical examination and perfusion lung scan were normal, and a detailed cardiac evaluation was within normal limits. The neurological examination, including sensory and motor functions, was normal except for brisk reflexes. She had no further episodes of chest Plasma lipld profiles were determined by using the protocols of the Lipid Research Clinics. Plasma concentrations of apo B and apo A-l were determined by established radiolmmunoassay, and apo E Isoforms were analyzed on isoelectrlc focusing gels as described in the Methods section. Apo B phenotypes were assigned on the basis of Western blotting analyses described in the Results section. WS2 and WS3 are father and son, respectively, from a second kindred, and GM is from a third kindred. REF is the reference donor.
Ht •= height, Wt = weight, chol = cholesterol, TG = trigryceride, LDL = low density llpoprotein, HDL = high density lipoprotein, Apo = apoprotein.
pain and was discharged with instructions to refrain from smoking, which she did. She was seen at the Upid Research Center 1 week later for determination of plasma cholesterol concentrations. Her total cholesterol at that time was 75 mg/dl, high density lipoprotein (HDL) was 51 mg/dl, LDL was 20 mg/dl, and triglycerides were 41 mg/dl. She has not had any further episodes of chest pain since her hospital discharge.
Blood samples were obtained on six other members of the kindred ( Figure 1 , Table 1 ). One sister, II-3, had a history of mitral valve replacement and hypertension and was taking digoxin and a diuretic at the time her blood sample was obtained. Another sister, II-7, had a history of chronic bronchitis and was taking theophylline, quiafenesin, and tetracycline. Her surgical history included a cholecystectomy and an appendectomy. Two brothers, II-8 and 11-11, were healthy, without significant history of illness. No member of the family had a history of neurologic impairment, but the mother (I-2) and one brother (II-2) were reported by the family to have died of myocardial infarction. Independent confirmation of their deaths was unobtainable.
One control group for this study consisted of three hypocholesterolemic subjects. Their lipid values are listed in Table 1 . WS2 is a 58-year-old healthy man with a history of migraine headaches, for which he was taking Cafergot. WS3 is the son of WS 2. He is 23-years-old and healthy except for migraine headaches and allergic rhinitis, for which he was taking Seldane and Cafergot. GM is a 28-year-old healthy man. Other controls consisted of normolipidemic, healthy individuals. LDL from a normolipidemic reference (REF) donor was used in many of the competition immuno-and cell binding assays.
Blood Collection and Plasma Analyses
Blood from fasted donors was drawn into tubes containing ethylenedinitrilotetraacetic acid (EDTA) (1.0 mg/ ml). Blood cells were separated from plasma by centrrfugation, and the following protease inhibitors were added promptly to the plasma: 20 /iM D-phe-L-phe-L-arg chlcromethylketone (PPACK) and 20 /iM D-phe-L-pro-L-arg chloromethylketone (Pierce Chemical Co., Rockford, IL) to respectively prevent the kallikrein or thrombin cleavage of apo B-100. 17 Packed blood cells were stored under sterile conditions at -20°C before isolation of deoxyribonucleicacid (DNA). Concentrations of total plasma triglycerides and cholesterol and HDL cholesterol were determined by standard Lipid Research Clinic techniques in the Core Laboratory of the Lipid Research Center. 18 Total plasma apo B-100 concentrations were determined by a well-established, routine polyclonal radioimmunoassay described previously. 19 Apo E phenotyping of the study subjects by isoelectric focusing was performed on neuraminidase-treated VLDL by using a Pharmacia Phastgel system.
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Separation of Plasma Upoprotelns by Fast Protein Uquld Chromatography
Plasma (without any additives) was applied onto two Superose 6 HR 10/30 (25 ml) columns connected in series as described previously. 22 The FPLC system consisted of a P-500 pump, an LCC-500 gradient programmer, a V-7 injection valve, a 1.5 ml injection loop, a single-path detector, a FRAC-100 fraction collector, and a chart recorder. Plasma (2 ml) was centrifuged immediately before application onto the Superose 6 columns at 12 000 g in a microfuge for 10 minutes at ambient temperature. The columns were equilibrated and eluted at ambient temperature with a buffer consisting of 1 mM EDTA and 0.15 M NaCI, pH 8.0. Plasma was applied to the columns (1.5 ml) and eluted at a flow rate of 0.5 ml/ min. The elution of proteins was monitored by absorbance at 280 nm. The initial 12 ml of eluent were diverted to waste, and subsequent eluent was collected in 60 fractions of 0.5 ml. The runs continued until a total volume of 60 ml had run through the column, thus allowing complete elution of plasma proteins and salts. The column eluent fractions were analyzed for cholesterol and trigryceride as TWO TRUNCATED APOUPOPROTEIN B SPECIES IN HYPOBETAUPOPROTEINEMIA Kml et al. 859 described below. In some cases, the fractions were analyzed for apo B content by radioimmunoassay.
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Isolation and Storage of Reference and Sample Low Density Upoproteln Preparations
LDL was isolated from plasma by sequential ultracentrifugation between the densities of 1.019 and 1.063 g/ml. 23 The LDL preparations were dialyzed at 4°C against the following: 50 mM borate buffered saline, 20 fM diethylenetriamine pentaacetic acid (DTPA), and 0.13% (wt/vol) eamino caproic acid, pH 7.4. The LDL preparations were sterile-filtered and stored tightJy capped under N 2 at 4°C in the dark. LDL preparations stored in this manner were stable over several weeks. The apo B-100 mass in the LDL preparations were measured by routine radioimmunoassay (RIA). 19 REF LDL was isolated regularly from the same normolipidemic individual.
Thrombln Digestion of Low Density Upoproteln Preparations
LDL preparations from several study subjects were tested by thrombin digestion to determine whether all preparations yielded similar patterns of proteolyrically cleaved peptides. LDL isolated as described above was dialyzed against 10 mM Tris-HCI, 0.3 mM EDTA (pH 8.0). For thrombin digestion, LDL was incubated with 4% (by weight) of purified human thrombin (3000 U/mg) for 48 hours at 37°C. (Purified thrombin was a generous gift of Phillip Majerus, Washington University School of Medicine.) Digestion by thrombin was stopped by the addition of PPACK to a final concentration of 1 fiM.
Electrophoresls and Immunoblottlng
LDL apo B was analyzed by electrophoresis of delipidated LDL on gradient 3% to 6% sodium dodecyl sulfate (SDS) polyacrylamide gels as previously described. 24 Electrophoresis of plasma on gradient 3% to 6% SDSpolyacrylamide gels was performed as described by Menzel and Utermann. 25 Aside from being a rapid and simple technique, it was noted that Western blot analyses of apo B in samples of plasma showed little or no evidence of proteolytic degradation of apo B as is occasionally seen using isolated LDL Also, using whole plasma ensured that all apo B species in plasma would be identified, especially in view of the possibility that abnormal apo B species would not float in the classic LDL density range. In some cases, LDL and HDL preparations were analyzed for particle size distribution by nondenaturing gradient polyacrylamide gel electrophoresis (GGE) on 2% to 16% and 4% to 30% Pharmacia PAA gels, respectively. 26 Electrotransfer of proteins separated by SDS-polyacrylamide gel electrophoresis (PAGE) was carried out according to the general procedure of Towbin et al. 27 by using Tris methanol transfer buffer. Five percent (wt/vol) non-fat dry milk in phosphate-buffered saline (PBS) was used to block the remaining protein binding sites on the nitrocellulose transfers. Transfers were incubated at 23°C overnight with 10 /xg/ml purified monoclonal antibodies, 28 after which the immunoblots were washed by using an Omniblot apparatus (American Bionuclear, Emeryville, CA) with 0.1% (wt/ vol) Triton and 0.1% (wt/vol) Tween-80 in PBS. Immunoblots were then incubated for 4 hours at 23°C with 750 000 cpm/ml affinity purified 125 l-goat antimouse IgG, after which they were washed as described above, dried, and exposed to Kodak XAR-5 film at -70°C for autoradiography.
Restriction Fragment Length Polymorphism and Variable Number of Tandem Repeat Pedigree Analysis
DNA from leukocytes was extracted with Triton X-100 29 and was digested with the restriction enzymes, Pvu II, Xba I, and EcoR I (2 to 10 units//xg DNA) under conditions recommended by the manufacturers (Anglian Biotechnology, Colchester, UK). DNA fragments were separated by size on a 1% (Pvu II and Xba I) or 0.7% (EcoR I) agarose gel and were transferred to Hybond-N (Amersham International, Amersham, UK) by Southern blotting as described previously. 30 The DNA probes used were: a 3.5 kb EcoR I unique fragment (pAB3.5C) of the apo B gene to detect the Xba I restriction fragment length polymorphism (RFLP), 31 a 2 kb Hind III unique fragment (BH2) to detect the EcoR I RFLP, and a 959 bp cDNA probe to detect the Pvu II RFLP. 32 The labeling of probes, hybridization, and washings were carried out as described previously. 33 The 3' flanking hypervariable region of the apo B gene was amplified by using the Polymerase Chain Reaction (PCR) 34 and the typing method reported by Boerwinkle et al. 35 One /xg of genomic DNA was amplified by using 1 /ig of each primer. The 5' oligonucleotide primer was 5'-ATGGAAACGGAGAAATTATG-3', and the 3' oligonucleotide primer was 5'-CCTTCTCACTTGGCAAATAC-3'. Three units of Taq polymerase (Perkin-Elmer Cetus, Norwalk, CT) were used in each reaction, together with the buffer and deoxynucleoside triphosphates as recommended by the manufacturer. The reaction was carried out in a final volume of 100 /J. The amplification protocol was 1 minute in a 94 C C waterbath and 6 minutes in a 58°C waterbath repeated for 26 cycles. The amplification products of variable number of tandem repeats (VNTR) alleles are distinguished by their length and may be visualized directly after electrophoresis of the DNA on a 2% agarose gel with ethidium bromide.
Cell Binding and Degradation of Upoprotelns by Flbroblasts In Culture
Human fibroblasts (GM0203), which were normal for LDL receptor binding activity, 38 were obtained from the National Institute of Health Cell Repository. LDL binding and degradation assays with human fibroblast cultures were performed according to the methods of Goldstein and Brown. 37 Fibroblasts were grown in culture dishes as described previously, 38 and experiments were begun after incubation in lipoprotein-deficient serum (LPDS) for 48 hours. In some experiments, sample and reference LDLs were added to the cell cultures in media containing 10% LPDS simultaneously with a constant amount of REF In experiments where monoclonal antibodies were tested for their abilities to inhibit LDL binding to fibroblasts, increasing concentrations of purified monoclonal antibodies (MAbs) were added to constant amounts of 12S I-LDL preparations. These mixtures were incubated at 37°C for 30 minutes before being applied to monoiayers of fibroblasts at 4°C. In all cases, incubations of the lipoproteins with cells were carried out for 4 hours. At the end of the incubations, the proteolytic degradation of the 125 l-labeled LDL by the fibroblasts at 37°C was determined by measuring the trichloroacetic acid(TCA)-soluble material in the spent medium after removal of the free iodide with chloroform. 37 LJpoprotein binding was determined after fibroblasts were washed, dissolved in 0.1 M sodium hydroxide and aliquots counted for cell-associated radioactivity as described previously. 38 Additional aliquots were taken to determine total cell protein. Nonspecific binding or cell association were determined as the amount of bound or cell-associated radioactivity after incubation of 125 l-labeled LDL in the presence of at least a 50-fold excess of nonlabeled homologous lipoprotein. Nonspecific degradation was determined as TCA-soluble radioactivity in media containing 126 I-LDL incubated in cell-free culture dishes.
Other Methods
Protein was measured by the method of Lowry et al. 39 Unesterified and esterified cholesterol and phospholipids were measured with enzymatic kits (Wako Fine Chemicals, Dallas, TX). Triglycerides were determined with a Technicon RA500 autoanalyzer (Technicon Diagnostics, Tarrytown, NY). The latter method permitted correction for values that arose due to the presence of any endogenous glycerol. Figure 1 shows the pedigree of the SH kindred and the apo B haplotypes of the family members derived from the monoclonal antibody and molecular analyses described below. The proband (11-1) had very low plasma concentrations of apo B and total plasma and LDL cholesterol concentrations that were well below the 5th percentile compared to sex-and age-matched controls 40 (Table 1) . Analytical 3% to 6% gradient SDS-PAGE of delipidated 11-1 plasma on several occasions over a 10-month period revealed the presence of an abnormal protein band migrating with an apparent molecular weight that on initial approximation appeared to be 90% that of apo B-100 and from here on will be referred to as apo B-90 (Figure 2 , lane 11-1). No apo B-100 was present in the plasma of the proband. The plasmas of normolipidemic reference subjects and unrelated subjects with HBL (Table 1) were collected and processed under identical conditions and exhibited apo B-100, but no apo B-90 (Figure 2 ).
Results
Apoproteln B Species In Plasma and Upoprotelns of the SH Kindred
To evaluate whether abnormal apo B-90 is an inherited trait, the plasmas of six available family members were also subjected to 3% to 6% SDS-PAGE. LDL was used for the analyses of a seventh family member 11-11 (not shown). Coomassie blue staining of the SDS-PAGE gels ( Figure 2 , top panel) of plasma revealed that one sibling (II-8) had both apo B-100 and apo B-90, and the other three individuals (11-1, II-3, II-7) appeared to have only apo B-90. A brother (11-11) (not shown) as well as a wife of II-8 (II-9) appeared to have only apo B-100 (Figures 1 and  2 ). However, an additional band with an approximate molecular weight of apo B-40 was faintly seen on Coomassie-stained gels of isolated LDL (see Figure 4B ) and was clearly evident on Western blots of some samples with MAb C1.4 ( Figure 2, middle panel) . The C1.4 epitope has been assigned between apo B-100 amino acids 97 and 401 ( Figure 3) . 24 Based on the Western blotting analyses, three siblings were assigned genotypes apo B-90/apo B-40 ( Figure 3) , apo B-100 reacted, but apo B-90 and apo B-40 did not (Figure 2, lower panel) . Similarly, apo B-90 bound MAbs D7.2 and B1B3 but apo B-40 did not ( Figure 4B ). The epitopes for MAbs D7.2 and B1B3 are between amino acids 1878 and 2148 and 3506 and 3635, respectively (Figure 3) . 24 The immuneblotting data suggest that apo B-90 and apo B-40 represent two different protein variants wtth deletions of the carboxyl terminal portion of apo B-100; the former representing a shorter deletion at the carboxyl terminal compared to the latter. These data were confirmed in solid- phase immunoassays by using a panel of MAbs and isolated LDL from the proband and her kindred (data not shown). MAb B6C3 was the only antibody that did not bind apo B-90-containing LDL, whereas all other MAbs demonstrated normal binding of apo B-90 LDL (Apo B-40 does not constitute a significant mass of protein compared to apo B-90 in isolated LDL, and therefore differences in antibody binding for those epitopes absent in apo B-40 were not readily detected.)
To measure the sizes of the apo B-90 and apo B-40 species more accurately so that the termination sites of apo B-40 and apo B-90 along the apo B-100 molecule could be determined more precisely, Western blotting experiments were performed on apo B-100 and apo B-90-containing LDL and on thrombin-treated preparations of these lipoproteins (Figures 4A and 4B) . Using the apparent molecular weights of apo B-100 and its thrombin fragments assigned by Cardin et a)., 17 we determined by SDS-PAGE that apo B-90 and apo B-40 had apparent molecular weights of 487 300± 14 100 (mean±SD (apo B-89+3) and 220 700+12 300, (apo B-40±2). Thus the carboxyl terminal amino acids of apo B-90 and apo B-40 should be near apo B-100 residues 4082 and 1878, respectively.
When digested with thrombin, the LDL protein of the proband with the apo B-90/40 genotype ( Figure 4A (proband) and Figure 4B , panel NC, Lane 2) yielded T1, T3, and T4 fragments that were of the same size as those obtained upon digestion of apo B-100 LDL, but no normalsized T2 fragment was detected. The T1, T3, and T4 fragments were derived from apo B-90. Apo B-40 would be predicted to give rise to only two thrombin cleaved fragments: a normal-sized T4 and a truncated T3. The latter would be estimated to have a molecular weight of approximately 57 000 and would run with the solvent front on the 3% to 6% gel shown in Figures 4A and 4B and thus is not detectable by Coomassie blue stain. The normal LDL apo B-100 gave rise to a T2 fragment of expected size, but no apo B-40 or apo B-90 sized bands were produced. By contrast, thrombin digestion of apo B-90,40 LDL gave rise to an abnormal sized protein fragment seen on Coomassie blue-stained gels ( Figure 4A , Thr-P LDL) or Amido blackstained nitrocellulose transfers ( Figure 4B , panel NC, Lane 2). This band had an apparent molecular weight of 109 150±9400 and was designated as T2*. MAb B1B3 reacted with normal T2 and also with T2* ( Figure 4B ) confirming that T2* is a truncated version of normal T2.
Restriction Fragment Length Polymorphism and Variable Number of Tandem Repeats Pedigree Analysis
The PCR was used to amplify the 3' flanking hypervariable region of the apo B gene consisting of VNTRs of a 16 to 18 bp A-T rich consensus sequence. 41 The apo B 3' VNTR can be detected by a number of restriction enzymes that span the hypervariable region (Msp I, Xba I, and Hind III have been used) and hybridized with an apo B 3' probe. Utilizing the PCR with priming nucleotides allows one to separate alleles that differ by only 32 bp. The nomenclature is based on the number of repeat units; for example, an allele with 37 repeats of the consensus sequence is labeled 3'037 following the recommendations of Boerwinkle et al. 36 In Figure 5 , the consecutive lanes labeled 11-1 to 11-11 show the amplification products of all the available family members used in the pedigree analysis. Lanes marked M are the PCR products of two unrelated individuals (control samples) used as size markers and estimated as 3'047 to S'pXS. 35 Lanes 10 to 12 have amplified DNA from two family members mixed in different combinations to verify the allele sizes. Lane 12 is a combination of DNA from individual II-8 (apo B-90/ apo B-100) and from individual 11-11 (apo B-40/apo B-100). All four alleles could be visualized: B-90 3'/339, B-40 3'£37, B-100 3'/335, and B-100 3'/329. These were sized according to the previously sized control DNA fragments that were run in the lanes marked M (Figure 5 ). Amplified DNA from individual II-9, the spouse of II-8, shows two alleles typed as 3'/337 and 3'/347. The most common VNTR allele is 3'037. 36 Lane 11 has DNA combined from individuals II-8 and II-9 and shows four alleles. Their daughter (111-1) has inherited the B-100 3'/337 from the mother and trie B-100 3'/329 from the father.
It was possible to haplotype all four parental alleles as follows: apo B-100 X1R1P2 3'/329, apo B-100 X2R1P1 3'035, apo B-90 X2R1P1 3'/339, and apo B-40 X2R1P1 3'037. Thus, three RFLPs and the VNTRs of the apo B gene were used together to determine the haplotypes of the SH kindred ( Figure 1 ) and, therefore, to follow the inheritance of the four parental apo B alleles through the family. In this way, the inheritance of the two truncated species was determined and in all cases confirmed the results from monoclonal antibody binding studies.
Characterization of Upoprotelns
Lipoprotein distributions of several family members were obtained by gel filtration chromatography of plasma on Superose 6 columns ( Figure 6 ). Peak fractions of ultracentrifugally isolated VLDL (d<I.006g/ml), LDL (1.030 to 1.050 g/ml), and HDL (1.063 to 1.21 g/ml) from normolipidemic plasma elute between fractions 6 and 9, 26 and 28, and 44 and 46, respectively (see horizontal bars in Figures 6A and 6B ). In the three family members with apo B genotype apo B-90,40, the cholesterol and triglyceride profiles demonstrated that VLDL eluted at the normal position, but peaks of LDL and HDL cholesterol eluted later than the corresponding peaks from normolipidemic or unrelated hypobetalipoproteinemic individuals (Figure 6A) , suggesting that smaller LDL and HDL particles were present. This was confirmed for LDL in subject 11-1 by electron microscopy. The 1.019 to 1.063 g/ml fractions of plasma from subjects 11-1, GM, and REF (Table 1) had mean diameters (± 1 SEM, n=200) of 248±6 A, 261 ±6 A, and 264±6 A, respectively. HDL profiles obtained upon gel filtration of plasma from the apo B-90/40 genotypic subjects had distinct shoulders, indicating the presence of a population of very small HDL particles (Fractions 52 to 56). Small particles were seen also on GGE (data not shown). Small HDL were not seen in the plasmas of fasted normolipidemtc individuals. The elution positions of lipoproteins of the subject with apo B genotype apo B-100/40 were normal ( Figure 6B , top panel), and subject II-8 with genotype apo B-100/90 exhibited normal sized LDL on GGE (not shown). Radioimmunoassay of apo B in column fractions ( Figure 6 ) indicated that most apo B was present in LDL, and again that LDL particles in plasma of subjects II-3 and II-7 were smaller than those of normolipidemic individuals and the unrelated HBL controls (Figure 6 ). Small amounts of apo B were detected in the LDL-HDL overlap regions.
It should be noted that for the apo B-90/apo B-40 heterozygotes, the plasma apo B distribution among the column fractions largely reflects the distribution of the apo B-90 species, as this was the major form of apo B in the apo B-90/apo B-40 heterozygotes. Upoproteins isolated in the LDL (1.019 to 1.063 g/ml) and HDL (1.063 to 1.21 g/ml) density range from plasmas of apo B-90/apo B-40 subjects were examined by SDS-PAGE (not shown). The LDL and VLDL fractions (not shown) consisted primarily of apo B-90, whereas the denser HDL fraction had a higher proportion of apo B-40 relative to apo B-90. Electrophcresis and immunoblots on SDS-PAGE of discrete lipoprotein subtractions of densities 1.063 to 1.090, 1.090 to 1.124, and 1.124 to 1.21 g/ml revealed that apo B-90 was proportionately the predominant detectable apo B species in densities up to 1.124 g/ml (not shown). Apo B-40 was the only detectable apo B species in the d>1.124 g/ml fraction. In this regard, the apo B-40 is similar to the apo B-37 species reported by Young et al. 7 in that it is found in particles with HDL density; however, it should be noted that apo B-40 is found in much lower concentrations in plasma and HDL than apo B-37. Also, there was no evidence of a "peak" of apo B-40 in the HDL density range as was reported for apo B-37 by Young et al.
Chemical compositions of ultracentrifugally isolated LDL (1.019 to 1.063 g/ml) from members of the SH kindred and various controls were variable, and there were no correlations between LDL composition and apo B genotype (Table 2) . Similarly, there were no correlations between
B-100-B-90-
TI-
B-40'
T2 T4 T2'
Rgure 4. Thrombin digestion of nonmolipoproteinemic (Norm) low density lipoprotein (LDL) and LDL from 11-1 (proband) used to identify regions of apo B-100 protein present in the abnormal apo B species. Partial thrombin digestion was performed as described in the Methods section. Each LDL preparation was boiled in sodium dodecyi sulfate (SDS) sample buffer, and 3 jtg of control. Undigested LDL and 10 ^g thrombin of digested LDL were applied to 3% to 6% sodium dodecyl surfate-polyacrylamide (SDS-PAGE) gels as described in the Methods section. The major apo B species, as well as the major thrombin apo B-100 cleavage products, are indicated. A. Coomassie blue-stained gel of normal B-100-containing LDL (Norm), 11-1 LDL (proband), and thrombin-dlgested normai (Thr-N) and proband (Thr-P) LDL Thrombin-digested normal and proband LDL were mixed In a 1 : 1 ratio and applied to the last lane (Thr-N+Thr-P). Thrombin digestion of proband LDL gave rise to normal sized T1, T3, and T4 fragments. Normal sized T2 was absent, but a lower molecular weight band (T2*) was apparent In thrombin-dlgested proband LDL B. Western blot analysis of thrombin-digested normal (Lanei) and proband (Lane 2) LDL. Thrombin-digested LDL preparations were electrophoresed on 3% to 6% SDS-PAGE gels as indicated in A. Proteins on replicate gels were electrotransferred to nitrocellulose and stained with amido black (NC) or Incubated with three monoclonal antibodies (MAbs) directed toward the amino terminus (C1.4), the middle region (D7.2), and the carboxyl terminal region (B1B3) of apo B-100. Apo B-40 and T3 17 have apparent molecular weights of 220 700 and 238 000, respectively, and cannot be dearly distinguished on the 3% to 6% SDS-PAGE gels shown here. MAb C1.4 does not bind the T3 fragment of apo B-100 ( Figure 3) ; therefore, the band reactive with MAb C1.4 in Lane 2 is apo B-40. The additional band below T1 reactive with D7.2 in Lane 1 probably represents one of the minor thrombin cleavage products of apo B-100 17 and corresponds to an apo B-100 fragment lacking an amlno terminus. This fragment can be seen on the amido black-stained nitrocellulose. The band reactive with D7.2 in Lane 2, which migrates above T3, Is likely the same minor thrombin cleavage product derived from apo B-90. 
Cell Association and Degradation of Upoprotelns by Flbroblasts
To determine how apo B-90 or apo B-40 give rise to hypobetalipoproteinemia, LDL from the proband was tested for its ability to compete with REF (Figures 7A and 7B ). This was confirmed in a second experiment at 37°C by using a range of LDL concentrations (not shown). We also evaluated the inhibitory properties of LDL preparations on the binding of Figure 5 . Variable number of tandem repeats (VNTR) typing of family members. One mlcrogram of genomic DMA from control samples (previously sized) and from members of the proband's kindred was amplified by using priming oligonucleotides and Taq polymerase. After amplification, the hypervariable DMA fragments were visualized directly on the agarose gel with ethidium bromide. The numbers 3'/347, 3'/341, 3'037, and 3'/333 represent the sizing of the 3' VNTRs based on the number of repeats (47 to 33) of the A to T consensus sequence in control DNA. Lanes labeled M represent combined DNA from two unrelated individuals (control samples) used as size markers. Lanes correspond to DMA from the indicated family members: 11-1, II-3, II-8, II-9,111-1, II-7, and 11-11. Lanes 10 to 12 represent mixtures of DNA from members II-1+II-11, II-8+II-9, and II-8+II-11, respectively. Based on the control size markers, the apo B-90 allele, present in individuals 11-1, II-3, II-8, and II-7 was sized as 3'039. The apo B-40 allele present in individuals 11-1, II-3, II-7, and 11-11 was sized as 3'037. The two apo B-100 alleles were sized as 3'/335 and 3'f329. Thus, in Lane 10 three bands are seen, apo B-90 (3'039), apo B-40 (3'/337) contributed from both samples, and apo B-100 (3'035). Lane 11 has four fragments from II-8 and II-9. Lane 12, consisting of a combination of DMA from II-8 and 11-11, shows all four apo B parental alleles, confirming that they are different and distinguishable by using the VNTR typing. Table 1 inhibitors than apo B-100 LDL (maximum inhibition at 10 to 20 ^g/ml and EDSQS 1.6 times less than apo B-100 LDL). Apo B-90 must be the ligand mediating the binding of apo B-90,40 LDL to cells, because none of the apo B molecules comprising ^48% of the amino to carboxyt length of apo B-100 studied to date react with LDL receptors. 42 - 43 Since apo B-40 does not bind to the LDL receptor, then the finding that 10 to 20 /xg of apo B-90 is required to maximally inhibit the binding of 4 ^g of 12S l-labeled apo B-100 is an overestimate. To confirm that the binding of LDL from the apo B-90/ apo B-40 heterozygotes was mediated by apo B-90 and not due to trace amounts of apo E present in the d=1.019 to 1.063 g/ml fraction, LDL from the proband (SH), a hypobetalipoproteinemic control (GM), and the REF donor were each radblabeted and incubated (8 jzQ/ml) with fibroblasts at 4 C C in the absence or presence of three monoclonal antibodies ( Figure 9 ). In the presence of an anti-apo E MAb, which inhibits apo E-mediated binding to the LDL receptor, 3844 no inhibition of any LDL binding was observed. An anti-LDL MAb (CE6-1) directed to the central T3 region of apo B was also without effect However, MAb B1B6, which blocks apo B-100-mediated binding of LDL to its receptor 38 and binds apo B-90, inhibited the binding of SH LDL to fibroblasts to the same extent that it inhibited the binding of GM LDL or REF LDL (Figure 9 ).
Discussion
Two novel variants of apo B are reported here, apo B-90 and apo B-40, with calculated molecular weights of 487 300+14 100 and 220 700±12 300, respectively. By using a combination of RFLP and VNTFt typing, it was possible to distinguish all four parental alleles in the SH kindred. Other truncated variants of apo B, apo B-37, 10 apo B-39, and apo B-29, which are due to gene mutations that result in premature termination of the transcription of apo B mRNA have been described. 11 There are differences between apo B-40 and the other previously described truncated apo B species. Apo B-40 was distributed in VLDL, LDL, and HDL density fractions, whereas apo B-39 was only detected in VLDL/chylomicron and LDL fractions of affected individuals. 11 The majority of apo B-37 was primarily contained in the HDL fraction, with little in VLDL and LDL, and was present in plasma at higher concentrations than apo B-40. (M,=489 150) with the molecular weight of apo B-90 calculated on the basis of its migration in SDS-PAGE gels (H=487 300).
Molecular analysis of the DNA mutations giving rise to apo B-90 and apo B-40 are heretofore undescribed mutations of the apo B gene (data to be published elsewhere). Both apo B-90 and apo B-40 appear to contribute to the hypobetalipoproteinemia in this kindred. Heterozygosity for either allele alone in conjunction with apo B-100 (siblings II-8 and 11-11) was associated with low apo B and 5th percentile values for total plasma and LDL cholesterol values ( Table 1 ) and lack of inhibition by a second anti-apo B-100 MAb CE6-1 (directed toward amino acid residues 1878 to 2148), and anti-apo E MAb WU E-4. The latter antibody blocks apo E-mediated binding of lipoproteins to cells.
38 LDL (1.019 to 1.063 g/ml) was Isolated from the proband (11-1), the normolipidemic reference REF donor, and an unrelated hypobetalipoproteinemic subject (GM), and all three preparations were radloiodinated as described in the Methods section to a mean specific radioactivity of 184±22 cpm/g. Increasing concentrations of MAbs were added to a constant amount of each radioiodlnated LDL preparation (8 jig/ml) and incubated at 37°C for 30 minutes before being added to monolayer cultures of fibroblasts. Values represent the percent of cellular 12S l-binding in the presence of the added MAbs compared to the binding observed In the absence of any added MAb. had higher plasma levels than did the apo B-100/apo B-40 heterozygote, and compound heterozygosity for both alleles resulted in a marked reduction in apo B total plasma and LDL cholesterol concentrations (Table 1) . Thus the size of the apo B deletion may be related to the plasma concentrations of apo B and LDL. Kinetic studies need to be done to be certain, but selective removal of apo B-90 LDL is probably responsible for the greater by guest on October 23, 2017 http://atvb.ahajournals.org/ Downloaded from concentrations of apo B-100-vs. apo B-90-containing LDL particles in ll-8's plasma. Certainly, the increased ability of apo B-90 LDL (compared with apo B-100) to bind LDL receptors is compatible with the more rapid clearance of apo B-90 LDL from plasma (Figures 7 and 8) . The ability of MAb B1B6 to bind to apo B-90 LDL and to inhibit the tatter's binding to cellular receptors (Figure 9 ) affirms that the structural integrity of the receptor recognition site on apo B-90 is intact. The increased ability of apo B-90 to bind to the LDL receptor on cells also suggests that domains of apo B distant from the LDL receptor binding region can influence apo B interactions with the receptor, perhaps by reducing the steric bulk, altering the net charge of the region, or increasing the molecular flexibility of the LDL receptor recognition region. In any case, it appears that the terminal amino acid residues are not necessary for the expression of the apo B receptor recognition site on LDL. For apo B-40, it is not clear whether the low plasma levels of this protein are due to reduced synthesis or secretion or to increased degradation. Since apo B-40 does not react with monoclonal antibodies with recognition sites near to the LDL receptor region of apo B-100, it is unlikely that apo B-40 LDL binds to the LDL receptor. Thus the reasons for the very low apo B-40 concentrations in plasma remain unknown at the present time. Similarly, apo B-37 does not bind to the LDL receptor of cells, and the sites of its clearance are not known. 43 It has been suggested that mutations in the apo B-100 gene resulting in very short truncated apo B variant proteins probably cause HBL due to an inefficiency of the shortened protein to package lipid in lipoprotein particles for export from cells. 11 Turnover studies in several subjects with familial HBL suggesting that these individuals synthesize VLDL at low rates 4 would be consistent with this idea. The relatively small deletion in apo B-100 giving rise to apo B-90 appears to be capable of binding normal amounts of lipid (normal lipoprotein compositions) but results in an HBL phenotype due to increased clearance of the apo B-90 by cells compared to apo B-100 as shown in the present study. The very low levels of apo Bcontaining lipoproteins present in the plasmas of compound heterozygotes and the higher concentrations in normal heterozygotes of the SH kindred also would be consistent with these latter two mechanisms. Finally, in the HBL family studied by Young et al. 8 there was evidence that a third and different type of mutation occurring at the apo B-100 gene locus causes lower apo B-100 concentrations, by an as yet unknown mechanism.
Many studies, including the present one, indicate that hypobetalipoproteinemia is genetically heterogeneous. 24 -8 This may account for some discrepancies in the literature as to whether or not HBL uniformly imparts increased longevity due to reduction in atherosclerotic disease.
4546
In this regard, it is noteworthy that the mother and a brother (II-2) of the proband in the present study apparently died as a result of myocardial infarctions in their fifth decades. Thus, studies of patients with different truncated variants of apo B or other mutations in the apo B gene will have profound clinical significance.
